Ms. Hoggatt covers the medical technology sector and some infectious disease and CNS indications. Ms. Hoggatt comes from Noble Financial where she was the Senior Medical Technology analyst. Prior to Noble, Ms. Hoggatt helped start the independent research firm, Variant Research with Dr. Weintraub and Dr. Henderson.
Before Variant she worked at Hibernia Southcoast Capital, where she was also a Medical Technology Analyst and a Vice President of Equity Research. Ms. Hoggatt began in the investment industry as an associate equity analyst at Morgan Keegan & Company covering medical devices and earned the title Associate Vice President of Equity Research. Her professional career has been focused on the healthcare sector and has included in-depth coverage of over thirty different companies in the Medical Technology and Medical Device industries, allowing her to share a wealth of knowledge and insight with our clients. Ms. Hoggatt received her Bachelors of Business Administration and Master of Accountancy from Millsaps College in Jackson, Mississippi.